| For: | Bianca C, Sidhartha E, Tiribelli C, El-Khobar KE, Sukowati CHC. Role of hepatitis B virus in development of hepatocellular carcinoma: Focus on covalently closed circular DNA . World J Hepatol 2022; 14(5): 866-884 [PMID: 35721287 DOI: 10.4254/wjh.v14.i5.866] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v14/i5/866.htm |
| Number | Citing Articles |
| 1 |
Corina Rotãrescu, Mariana Gelinas Martín del Campo, Ion Mãrunțelu. CHRONIC HEPATITIS B VIRUS INFECTION: WHERE WE ARE NOW. Romanian Archives of Microbiology and Immunology 2022; 81(3) doi: 10.54044/RAMI.2022.03.05
|
| 2 |
Sina Mahdavi, Mohammad Ali Abyazi, Hadi Esmaeili Gouvarchin Ghaleh, Reza Golmohammadi, Ali Salimi Jeda. Molecular insights into the mechanisms of occult hepatitis B virus infection. Archives of Virology 2026; 171(6) doi: 10.1007/s00705-026-06639-9
|
| 3 |
Kwon Yong Tak, Seok Hwan Kim, Myeong Jun Song. Hepatitis B core-related antigen as a multifaceted biomarker in chronic hepatitis B: implications for immune activity and hepatocellular carcinoma prediction. The Korean Journal of Internal Medicine 2026; 41(4) doi: 10.3904/kjim.2025.408
|
| 4 |
Pattida Kongsomboonchoke, Chaiyaboot Ariyachet, Pornchai Kaewsapsak, Pongserath Sirichindakul, Pisit Tangkijvanich. Development of a Sensitive and Specific RPA-CRISPR/Cas12a Assay for Intrahepatic Quantification of HBV cccDNA. International Journal of Molecular Sciences 2026; 27(1) doi: 10.3390/ijms27010551
|
| 5 |
Andrew F Ibrahim, Julie Sang, Pojsakorn Danpanichkul, Kwanjit Duangsonk, Ju Dong Yang, Thomas A Kerr, Amit G Singal. Current advances and future directions in the management of HBV-related hepatocellular carcinoma. Gastroenterology Report 2026; 14 doi: 10.1093/gastro/goag060
|
| 6 |
Yang-Hsiang Lin, Ming-Wei Lai, Chau-Ting Yeh, Wey-Ran Lin. Perspectives on NcRNAs in HBV/cccDNA-driven HCC progression. Cancer Cell International 2025; 25(1) doi: 10.1186/s12935-025-03849-0
|
| 7 |
Yutao Chen, Desheng Chen, Zhixing Liang, Haoyuan Yu, Haobin Sun, Yongwei Hu, Peng Jiang, Mingshen Zhang, Linsen Ye, Hua Li. Immune checkpoint inhibitors in hepatocellular carcinoma therapy: resistance mechanisms, liver transplantation challenges and management strategies. Cancer Drug Resistance 2025; doi: 10.20517/cdr.2025.120
|
| 8 |
Patricia Gita Naully, Marselina Irasonia Tan, Agustiningsih Agustiningsih, Caecilia Sukowati, Ernawati Arifin Giri-Rachman. cccDNA epigenetic regulator as target for therapeutical vaccine development against hepatitis B. Annals of Hepatology 2025; 30(1) doi: 10.1016/j.aohep.2024.101533
|
| 9 |
Yang-Hsiang Lin, Ming-Wei Lai, Yu-De Chu, Kwang-Huei Lin, Chao-Wei Hsu, Rong-Nan Chien, Po-Heng Chuang, Chih-Lang Lin, Chau-Ting Yeh. HBx mutant-regulated RPL13AP25 mediates suboptimal virological response to entecavir and HCC progression. Cancer Cell International 2025; 25(1) doi: 10.1186/s12935-025-03873-0
|
| 10 |
Bukhari Isah Shuaib, Usman Linda Itunu, Aminat Daud. Clinical utility of hepatitis B core-related antigen in chronic hepatitis B infection: diagnostic, prognostic, and therapeutic implications. Egyptian Liver Journal 2026; 16(1) doi: 10.1186/s43066-026-00512-9
|
| 11 |
Qinan Zhang, Bohan Zhang, Lei Wang, Yongjian Liu, Jingwan Han, Lei Jia, Hanping Li, Xiaolin Wang, Jingyun Li, Changyuan Yu, Lin Li. Comprehensive Transcriptomic and Epitranscriptomic Profiling of Hepatitis B Virus Transcripts in Two Hepatocellular Carcinoma Cell Lines. Genes 2025; 16(12) doi: 10.3390/genes16121397
|
| 12 |
Yassir Hamadalnil, Hisham N. Altayb. In silico molecular study of hepatitis B virus X protein as a therapeutic target. Journal of Biomolecular Structure and Dynamics 2024; 42(8) doi: 10.1080/07391102.2023.2217920
|
| 13 |
Hyung Joon Yim, Seong Hee Kang, Young Kul Jung, Sang Hoon Ahn, Won Kim, Jin Mo Yang, Jae Young Jang, Yong Oh Kweon, Yong Kyun Cho, Yoon Jun Kim, Gun Young Hong, Dong Joon Kim, Joo Hyun Sohn, Jin Woo Lee, Sung Jae Park, Sun Young Yim, Jin Kyung Park, Soon Ho Um. Reduced Risk of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Receiving Long-Term Besifovir Therapy. Cancers 2024; 16(5) doi: 10.3390/cancers16050887
|
| 14 |
Vishal S. Patil, Darasaguppe R. Harish, Rajitha Charla, Vishwambhar Vishnu Bhandare, Swarup S. Gujarathi, Faizan A. Beerwala, Priyanka P. Patil, Sunil S. Jalalpure, Harsha V. Hegde, Subarna Roy. Flavonoids of Andrographis paniculata regulate hepatitis B virus replication and hepatocellular carcinoma progression: evidence from computational and experimental studies. BMC Complementary Medicine and Therapies 2025; 25(1) doi: 10.1186/s12906-025-04807-z
|